Rituximab, Methotrexate, Procarbazine and Vincristine Followed by High-dose Chemotherapy With Autologous Stem-cell Rescue in Newly-diagnosed Primary CNS Lymphoma (PCNSL)
This study is ongoing, but not recruiting participants.
Study NCT00596154
Information provided by Memorial Sloan-Kettering Cancer Center
First Received on January 7, 2008.
Last Updated on August 9, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
